![Joel D. Sendek](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Joel D. Sendek
Directeur Financier/CFO chez
PERSPECTIVE THERAPEUTICS, INC.
Profil
Joel D.
Sendek currently works at Perspective Therapeutics, Inc., as Chief Financial Officer from 2025.
Mr. Sendek also formerly worked at Stifel Financial Corp., as Managing Director-Healthcare Equity Research from 2012 to 2014, Progenics Pharmaceuticals, Inc., as Senior Director from 1992 to 1996, Lazard, Inc., as Managing Director, Stifel, Nicolaus & Co., Inc., as Managing Director & Head of Equity Research from 2012 to 2014, FM Partners Holdings LLC, as Managing Director & Senior Analyst in 2011, Goldman Sachs & Co. LLC, as Principal in 1991, Gerard Klauer Mattison & Co., Inc., as Analyst, Forward Pharma A, as CFO & Principal Accounting Officer from 2014 to 2017, Spero Therapeutics, Inc., as CFO, Treasurer & Chief Accounting Officer from 2017 to 2019, and Forward Pharma USA, LLC, as Chief Financial Officer.
Mr. Sendek received his undergraduate degree in 1989 from William Marsh Rice University.
Postes actifs de Joel D. Sendek
| Sociétés | Poste | Début |
|---|---|---|
| PERSPECTIVE THERAPEUTICS, INC. | Directeur Financier/CFO | 04/09/2025 |
Anciens postes connus de Joel D. Sendek
| Sociétés | Poste | Fin |
|---|---|---|
| SPERO THERAPEUTICS, INC. | Directeur Financier/CFO | 08/11/2019 |
| FORWARD PHARMA A/S | Directeur Financier/CFO | 30/04/2017 |
Stifel, Nicolaus & Co., Inc.
 Stifel, Nicolaus & Co., Inc. Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01/07/2014 |
| STIFEL FINANCIAL CORP. | Directeur Technique/Scientifique/R&D | 01/07/2014 |
FM Partners Holdings LLC
 FM Partners Holdings LLC Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 31/12/2011 |
Formation de Joel D. Sendek
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
92
Relations au 1er degré
12
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
Stifel Financial Corp.
 Stifel Financial Corp. Investment ManagersFinance Operates as a bank holding company through its subsidiaries provides wealth and asset management, investment banking & trading services | Finance |
Progenics Pharmaceuticals, Inc.
 Progenics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets medicines for prostate cancer | Health Technology |
Lazard, Inc.
 Lazard, Inc. Investment Banks/BrokersFinance Provides financial advisory and asset management services | Finance |
Stifel, Nicolaus & Co., Inc.
Stifel, Nicolaus & Co., Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Goldman Sachs & Co. LLC
 Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Rice University
 Rice University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gerard Klauer Mattison & Co., Inc.
 Gerard Klauer Mattison & Co., Inc. Investment Banks/BrokersFinance Provides financial services such as investment banking, equity trading, asset management and management consulting services | Finance |
FM Partners Holdings LLC
FM Partners Holdings LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Forward Pharma A/S
 Forward Pharma A/S Pharmaceuticals: MajorHealth Technology Develops and manufactures proprietary formulations for inflammatory and neurological indications | Health Technology |
Spero Therapeutics, Inc.
 Spero Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of bacterial infections | Health Technology |
Forward Pharma USA, LLC | |
Perspective Therapeutics, Inc.
 Perspective Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops medical technology devices | Health Technology |
